NEW YORK (GenomeWeb News) – Eurofins MWG Operon today announced it has acquired gene synthesis firm Entelechon for an undisclosed amount.

Entelechon was founded in 1999 in Regensburg, Germany, and focuses on genomics and proteomics projects "bringing broad experience in the fields of gene optimization and synthesis," Eurofins MWG Operon, the genomics division of Eurofins Scientific, said. The company serves the drug manufacturing industry as well as academic and public research institutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.